CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Open-market sale Director sold 28,418 shares at an average $111.22 ($3,160,606)
- 4 Open-market sale Director sold 4,665 shares at $128.31 ($598,564)
- 4 Open-market sale Director sold 6,609 shares at $133.71 ($883,664)
- 4 Open-market sale Director sold 6,000 shares at $124.11 ($744,635)
- 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,303 shares (to pay taxes)
- 4 Open-market sale Director sold 6,297 shares at $131.00 ($824,907)
- 4 Open-market sale Director sold 1,000 shares at $130.27 ($130,270)
- 4 Open-market sale Director sold 6,572 shares at $87.51 ($575,142)
- 4 Open-market sale Director sold 5,322 shares at $87.50 ($465,691)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 4,385 shares at $85.15 ($373,373)
- 4 Open-market sale Director sold 4,093 shares at $85.10 ($348,322)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Grant or award Director acquired 2,821 shares (grant or award)
- 4 Exercise or conversion Director acquired 3,434 shares (option exercise)
Page 14 of 49 · 970 filings